Benzocaine 8 mg + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Sore Throat
Conditions
Sore Throat
Trial Timeline
Feb 2, 2018 → Apr 21, 2018
NCT ID
NCT03432923About Benzocaine 8 mg + Placebo
Benzocaine 8 mg + Placebo is a phase 3 stage product being developed by Johnson & Johnson for Sore Throat. The current trial status is completed. This product is registered under clinical trial identifier NCT03432923. Target conditions include Sore Throat.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03432923 | Phase 3 | Completed |
Competing Products
5 competing products in Sore Throat
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mg | Novartis | Phase 3 | 77 |
| Penciclovir + Placebo | Novartis | Approved | 85 |
| Diclofenac sodium gel 1% + Placebo | Novartis | Phase 3 | 77 |
| Angal S, topical spray [Menthol] + ANTI-ANGIN® FORMULA, topical metered spray | Sandoz Group | Phase 3 | 74 |
| Angal, lozenges [menthol], + ANTI-ANGIN® FORMULA | Sandoz Group | Phase 3 | 74 |